. 2016 Aug 10;6:31058. doi: 10.1038/srep31058

Table 2. Craniofacial outgrowth in larval exposure.

Exposure	STAGE	Group	EP³, μm	M, μm	EP/M, %
Larval exposure	2 dph	Control	135 ± 17^a	417 ± 30^a	32 ± 4^a
		Low dose	122 ± 17^b,c	395 ± 66^b	31 ± 4^a
		Pulse dose	132 ± 20^a,b	411 ± 24^a	32 ± 5^a
		High dose	118 ± 16^c	388 ± 28^b	30 ± 4^a
	9 dph	Control	219 ± 21^a	586 ± 45^a	37 ± 5^a
		Low dose	197 ± 27^b	557 ± 44^b	35 ± 5^a,b
		Pulse dose	199 ± 29^b	554 ± 47^b	36 ± 5^a,b
		High dose	170 ± 28^c	495 ± 39^c	34 ± 5^b
	18 dph	Control	314 ± 49^a	2442 ± 252^a	38 ± 5^a
		Low dose	295 ± 55^a,b	2324 ± 262^a	37 ± 6^a
		Pulse dose	263 ± 63^b	2216 ± 310^b	34 ± 5^a
		High dose	151 ± 39^c	1812 ± 165 ^c	25 ± 5^b

³EP, ethmoid plate; M, mandible.

^a–dLetters indicate significant differences between groups (p = <0.05) (groups with same letters are not significantly different from each other).